Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
New research presented at the Endocrine Societys 2025 Annual Meeting (ENDO 2025) has revealed that tirzepatidea medication originally developed for weight loss and type 2 diabetesmay offer surprising benefits for men suffering from both obesity and functional hypogonadism (low testosterone due to metabolic causes)
doi:10.3389/fpsyt.2021.546801 8
Current FDA-approved uses for semaglutide include : Type 2 diabetes management (glycemic control) Cardiovascular risk reduction in type 2 diabetes with established CVD (Ozempic) Cardiovascular risk reduction in adults with established CVD and obesity/overweight (Wegovy) Chronic weight management in obesity or overweight with comorbidities Clinicians should prescribe semaglutide according to FDA-approved indications and established clinical guidelines, including those from the American Diabetes Association (ADA) and American College of Physicians (ACP)
The pharmacy underwent expansion and needed re-certification in multiple states
US$ 25.64
US$ 28.24
US$ 22.77
US$ 24.77
US$ 25.89
US$ 26.18
US$ 23.42
US$ 27.80
